Beta-aminoketones as prodrugs for selective irreversible inhibitors of type-1 methionine aminopeptidases

We identified and characterized β-aminoketones as prodrugs for irreversible MetAP inhibitors that are selective for the MetAP-1 subtype. β-Aminoketones with certain structural features form α,β-unsaturated ketones under physiological conditions, which bind covalently and selectively to cysteines in...

Full description

Saved in:
Bibliographic Details
Main Authors: Altmeyer, Markus (Author) , Amtmann, Eberhard (Author) , Heyl, Carina (Author) , Marschner, Aline (Author) , Scheidig, Axel J. (Author) , Klein, Christian D. (Author)
Format: Article (Journal)
Language:English
Published: 23 September 2014
In: Bioorganic & medicinal chemistry letters
Year: 2014, Volume: 24, Issue: 22, Pages: 5310-5314
ISSN:1464-3405
DOI:10.1016/j.bmcl.2014.09.047
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bmcl.2014.09.047
Get full text
Author Notes:Markus Altmeyer, Eberhard Amtmann, Carina Heyl, Aline Marschner, Axel J. Scheidig, Christian D. Klein
Description
Summary:We identified and characterized β-aminoketones as prodrugs for irreversible MetAP inhibitors that are selective for the MetAP-1 subtype. β-Aminoketones with certain structural features form α,β-unsaturated ketones under physiological conditions, which bind covalently and selectively to cysteines in the S1 pocket of MetAP-1. The binding mode was confirmed by X-ray crystallography and assays with the MetAPs from Escherichia coli, Staphylococcus aureus and both human isoforms. The initially identified tetralone derivatives showed complete selectivity for E. coli MetAP versus human MetAP-1 and MetAP-2. Rational design of indanone analogs yielded compounds with selectivity for the human type-1 versus the human type-2 MetAP.
Item Description:Gesehen am 26.11.2020
Physical Description:Online Resource
ISSN:1464-3405
DOI:10.1016/j.bmcl.2014.09.047